期刊文献+

2型糖尿病伴冠心病患者血清胱抑素C水平及其意义 被引量:3

Plasma cystatin C in coronary heart disease complicated with type 2 diabetes mellitus
原文传递
导出
摘要 目的:探讨血清胱抑素C(Cys C)水平与2型糖尿病伴冠心病的关系。方法:收集40例单纯2型糖尿病患者(DM组)、120例2型糖尿病伴冠心病(CHD)患者(DM+CHD组)及40例健康者(对照组)的血清。分别测定基础代谢率、血压、血脂、血清糖化血红蛋白及Cys C水平。结果:血清Cys C水平在DM组[(1.58±0.78)mg/L]、DM+CHD组[(2.12±0.94)mg/L]较对照组[(0.82±0.23)mg/L]明显升高,差异有统计学意义(P<0.01),DM+CHD组明显高于DM组(P<0.05)。冠状动脉狭窄支数越多,血清Cys C水平越高。结论:2型糖尿病伴CHD患者的血清Cys C水平增高,且随冠状动脉狭窄病变支数的相应增加呈增高趋势,提示Cys C在2型糖尿病伴CHD的发生发展中起一定作用。 To investigate the effect of cystatin C (Cys C) on patients with type 2 diabetes mellitus (DM) and coronary heart disease (CHD). Method: The plasma from 40 patients with DM without CHD (DM group), 120 patients with DM and CHD (DM+CHD group), and 40 healthy person(control group) were collect-ed. The basic metabolism index, blood pressure, plasma level of lipid, glycosylated hemoglobin (HbAlc) and Cys C were measured. Result:The plasma levels of Cys C in DM group [(1.58±0.78)mg/L] and DM+CHD group [(2. 12±0.94)mg/L] were significantly higher than that in control group [(0,. 82±0.23)mg/L], and plasma Cys C in DM+CHD group was significantly higher than that of DM group. The more stenosed coronary, the higher level of plasma Cys C was. Conclusion:The levels of plasma Cys C in patients with DM and CHD were increased compared with that of DM group, and plasma Cys C was increased depending on the degree of coronary stenosis.
机构地区 解放军第
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2012年第7期539-541,共3页 Journal of Clinical Cardiology
关键词 冠心病 2型糖尿病 胱抑素C coronary heart disease type 2 diabetes mellitus cyst:atin C
  • 相关文献

参考文献15

  • 1DHARNIDHARKA V R, KVON C, STEVENS G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis[J]. Am J Kidney Dis, 2002,40 : 221 -- 226. 被引量:1
  • 2章毅,王永志.根据血清胱抑素C浓度推测肾小球滤过率的临床应用[J].中国血液净化,2004,3(12):655-656. 被引量:52
  • 3KOENIG W, TWARDEI.LA D, BRENNER H, et al. Plasma concentration of cystatin c in patients with coro- nary heart disease and risk for secondary cardiovascular e- vents., more than simply a marker of glomerular filtration rate[J]. Clin Chem,2005,51:321--327. 被引量:1
  • 4ER1KSSON P, DEGUCHI H, SAMNEGARD A, et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease[J]. Arterioscler Thromb Vasec Biol, 2004,24 : 551 -- 557. 被引量:1
  • 5SHLIPAK M G, SARNAK M J, KATZ R, et al. Cystatin C and the risk of death and cardiovascular e- vents among elderly persons[J]. N Engl J Med,2005, 352:2049--2060. 被引量:1
  • 6BATRA A, KAPOOR A, SHARMA R K, et al. As- sociation of plasma cystatin C levels with angiographi- cally documented coronary artery disease in patients of lndian origin[J]. J Cardiol,2012,59:182--189. 被引量:1
  • 7程方雄,曾昆,刘青建.冠心病患者血清同型半胱氨酸、高敏C-反应蛋白、胱抑素C水平变化及临床意义[J].临床心血管病杂志,2012,28(1):79-80. 被引量:35
  • 8IMAI A, KOMATSU S, OHARA T, et al. Serum cys- tatin C is associated with early stage coronary atheroscle- rotic plaque morphology on mnltidetector computed tomography[J]. Atherosclerosis, 2011,218 : 350-- 355. 被引量:1
  • 9DEO R, SHLIPAK M G, IX J H, et al. Association of cystatin C with ischemia in patients with coronary heart disease[J]. Ctin Cardiol, 2009,32 : E18- 22. 被引量:1
  • 10LUC G, BARD J M, I.ESUEUR C, et al. Plasma cystatin C and development of coronary heart disease: The PRIME Study[J]. Atherosclerosis, 2006,85 : 375 -- 380. 被引量:1

二级参考文献25

  • 1[1]Grubb A, Simonsen O, Sturfelt G, et al. Serum concentration of cystatin c, factor D and β2 - microglobulin as a measure of glomerular filtration rate. Acta Med Scand, 1985, 218:499 - 503 被引量:1
  • 2[2]Helen Stowe, David Lawrence, David J. Newman, and Edmund. Lambanalytical performance of a particle - enhanced nephelometric immunoassay for serum cystatin C using rate analysis. Clin. Chem, 2001, 47:1482- 1485 被引量:1
  • 3[3]Guido Filler, Friedrich Priem, Nathalie Lepage, et al. Trace protein,cystatin C, 2 - Microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin. Chem, 2002, 48:729 - 736 被引量:1
  • 4[4]Laterza OF,Price CP,Scott MG. Cystatin C: an improved estimator of glomerular filtration rate. Clin Chem, 2002,48:699 - 707 被引量:1
  • 5[5]Arend Bkenkamp, Joanna A.E. Van Wijk, et al. Effect of corticosteroid therapy on serum cystatin C and β2 - Microglobulin concentrations. Clin. Chem, 2002, 48:1123- 1126 被引量:1
  • 6[6]Rainer P. Woitas, Birgit Stoffel- Wagner, Uwe Poe ge, et al. Lowmolecular weight proteins as markers for glomerular filtration rate. Clin.Chem, 2001, 47:2179 - 2180 被引量:1
  • 7[7]Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C: a replacement for creatinine as a biochemical marker for GFR. Kidney Int,1994, 46:S20- S21 被引量:1
  • 8SABOURET P, CACOUB P, DALLONGEVILLE J,et al. REACH: international prospective observation- al registry in patients at risk of atherothromhotic e- vents. Results for the French arm at baseline and one year[J]. Arch Cardiovasc Dis, 2008,101 : 81 - 88. 被引量:1
  • 9NEWMAN D J, THAKKAR H, EDWARDS R G, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum ereatinine[J].Kidney Int, 1995,47 : 312- 318. 被引量:1
  • 10ARPEGARD J, OSTERGREN J, DE FAIRE U. Cystatin C a marker of peripheral atherosclerotic disease[J]. Atheroselerosis,2008,199 : 397- 401. 被引量:1

共引文献119

同被引文献64

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部